Akoustis Reports Record Revenue for Second Quarter Fiscal 2022 on 96% Sequential Growth
- Sales Momentum Continues as Revenue in the Current Q3 FY22 is Expected to Increase Over 25% Sequentially
- Robust Customer Activity and Design Win Pipeline in 5G Mobile, Wi-Fi CPE, 5G Infrastructure and Other Markets
- Company Adds Five New Wi-Fi Design Wins Since the End of Calendar 2021
- Successful Acquisition and Integration of Majority of RFM Integrated Device, Inc. (“RFMi”) Expand Product Portfolio
- Company to Host Investor Update Call Today at 8:00 am ET
Charlotte, N.C., Jan. 31, 2022 (GLOBE NEWSWIRE) --
Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today a 96% sequential quarterly revenue increase to a record $3.7 million for the second fiscal 2022 quarter ended December 31, 2021.
Based on robust activity in both the sales and design win pipeline, the Company expects to report another quarter of record revenue in the current March quarter with a top-line sequential increase of greater than 25%. The Company had $67.5 million in cash as of December 31, 2021.
Akoustis will host an investor call to provide a business update and outlook, followed by a Q & A session this morning at 8:00 a.m. ET. The call-in numbers are 877-407-3982 (domestic) or +01 201-493-6780 (international). The conference call will be webcast live on the Company’s website and will be available for playback at the following URL: https://ir.akoustis.com/ir-calendar.
Jeff Shealy, founder and CEO of Akoustis, stated, “Despite the ongoing macro headwinds presented by both COVID and semi-conductor supply chain shortages, Akoustis was able to achieve record revenue and unit growth in the December quarter and we expect that growth to continue. This is being driven as we ramp production of our patented XBAW™ RF filter solutions to multiple customers across the Wi-Fi 6, Wi-Fi 6E, 5G network infrastructure and other markets.”
Mr. Shealy continued, “We continue to experience strong demand and a growing sales funnel for our Wi-Fi, 5G mobile and CBRS XBAW™ filters, as well as our new RFMi resonator and oscillator products. As we announced this morning, we have recently added five new Wi-Fi design wins, all of which are expected to ramp into production in calendar 2022. We are equally excited that our business development efforts in 5G mobile were rewarded with two new, additional 5G customer engagements in the December quarter.”
Recent Business Highlights
- Announced today five new XBAW™ filter design wins in Wi-Fi including multiple MU-MIMO routers and other customer premise equipment
- Announced a purchase order from a new tier-1 5G mobile front-end module customer for the development of XBAW™ filters for mobile smartphones and other devices
- Received a Wi-Fi 6E design win for a MU-MIMO gateway product from a new customer
- Engaged with a third mobile customer for the development of 5G XBAW™ filters for smartphone and other mobile device applications
- Announced the acquisition of a majority ownership interest in RFMi having over 400 RF SAW resonator & filter and crystal resonator & VCO timing control products in its growing portfolio
- Entered the substantial timing control market with disruptive ultra-high-frequency XBAW™ resonators
- Received a design win and increased shipments to a tier-1 Wi-Fi 6E OEM
- Ramped production with multiple Wi-Fi 6E customers
- Continued the migration of the development and manufacture of new Akoustis’ WLP process into our New York fab
- Continued commercial production for Akoustis filters currently in a tier-1 consumer-focused tri-band Wi-Fi 6 product, which is currently sold both online and in retail stores
- Sampled a significant number of Wi-Fi 6E filters to tier-1 and tier-2 OEMs, ODMs and SoC customers
- Continued DARPA direct-to-phase II (DP2) contract to advance design and manufacturing of XBAWTM technology for filters and other sensors
- Received notification that the Company has been selected to negotiate terms for a new multi-year, multi-million-dollar contract with DARPA to scale XBAW™ technology up to 18 GHz
- Expanded XBAWTM patent portfolio to 56 issued and licensed patents plus 93 patents pending
Akoustis is actively delivering volume production of its Wi-Fi 6 tandem filter solutions, shipping multiple 5G small cell XBAW™ filter solutions, delivering initial designs of its new 5G mobile filter solutions to multiple customers and is now entering the market with its new Wi-Fi 6E coexistence XBAW™ filter solutions. The Company has more than ten new design wins over the past few months.
Given the rapidly growing sales funnel activity as well as ongoing interaction with customers regarding expected ramps in 5G mobile, Wi-Fi 6 and Wi-Fi 6E in calendar 2022, the Company plans to increase the annual production capacity at its New York fab to approximately 500 million filters per year.
Second Fiscal Quarter Financial Performance
| For the Three Months Ended December 31, 2021 |
For the Three Months Ended December 31, 2020 |
For the Six Months Ended December 31, 2021 |
For the Six Months Ended December 31, 2020 |
|||||||||||||
| Revenue | ||||||||||||||||
| Revenue with customers | $ | $ | 1,308 | $ | 5,540 | $ | 1,944 | |||||||||
| Cost of revenue | 4,549 | 2,602 | 7,451 | 4,251 | ||||||||||||
| Gross profit (loss) |
(877) |
(1,294 | ) | (1,911 | ) | (2,307 | ) | |||||||||
| Operating expenses | ||||||||||||||||
| Research and development | 9,192 | 5,566 | 17,166 | 11,946 | ||||||||||||
| General and administrative expenses | 5,146 | 3,361 | 9,022 | 6,288 | ||||||||||||
| Total operating expenses | 14,338 | 8,927 | 26,188 | 18,234 | ||||||||||||
| Loss from operations |
(15,215) |
(10,221 | ) | (28,099 | ) | (20,541 | ) | |||||||||
| Other (expense) income | ||||||||||||||||
| Interest (expense) income | 28 | (1,703 | ) | 62 | (3,135 | ) | ||||||||||
| Change in fair value of derivative liabilities | — |
14 | — | (184 | ) | |||||||||||
| Total other (expense) income | 28 | (1,689 | ) | 62 | (3,319 | ) | ||||||||||
| Net loss before income taxes | $(15,187) | $ | (11,910 | ) | $ | (28,037 | ) | $ | (23,860 | ) | ||||||
| Income Taxes | (58) | — | $ | (58 | ) | — | ||||||||||
| Net Loss | $(15,245) | $ | (11,910 | ) | $ | (28,095 | ) | $ | (23,860 | ) | ||||||
| Net loss (income) attributable to noncontrolling interest | (19) | — | (19 | ) | — | |||||||||||
| Net loss attributable to common stockholders | $(15,264) | $ | (11,910 | ) | $ | (28,114 | ) | $ | (23,860 | ) | ||||||
| Net loss per common share - basic and diluted | $(0.29) | $ | (0.30 | ) | $ | (0.54 | ) | $ | (0.61 | ) | ||||||
| Weighted average common shares outstanding - basic and diluted | 52,924,078 | 39,445,268 | 52,180,077 | 38,810,985 | ||||||||||||
| December 31, | June 30, | |||||||
| 2021 | 2021 | |||||||
| Assets | ||||||||
| Assets: | ||||||||
| Cash and cash equivalents | $ | 67,467 | $ | 88,322 | ||||
| Accounts receivable | 2,502 | 1,170 | ||||||
| Inventory | 2,286 | 1,390 | ||||||
| Other current assets | 3,158 | 2,314 | ||||||
| Total current assets | 75,413 | 93,196 | ||||||
| Property and equipment, net | 40,248 | 30,730 | ||||||
| Goodwill | 7,835 | — | ||||||
| Intangibles, net | 10,167 | 572 | ||||||
| Operating lease right-of-use asset, net | 389 | 471 | ||||||
| Other assets | 60 | 25 | ||||||
| Total Assets | $ | 134,112 | $ | 124,994 | ||||
| Liabilities and Equity | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable and accrued expenses | $ | 6,720 | $ | 6,954 | ||||
| Deferred revenue | 101 | 41 | ||||||
| Operating lease liability - current | 291 | 270 | ||||||
| Total current liabilities | 7,112 | 7,265 | ||||||
| Long-term Liabilities: | ||||||||
| Contingent liability | 1,082 | — | ||||||
| Operating lease liability | 94 | 202 | ||||||
| Deferred tax liability | 2,039 | — | ||||||
| Other long-term liabilities | 117 | 117 | ||||||
| Total long-term liabilities | 3,332 | 319 | ||||||
| Total Liabilities | 10,444 | 7,584 | ||||||
| Equity | ||||||||
| Preferred stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding | — | — | ||||||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 54,659,660 and 51,235,764 shares issued and outstanding at December 31, 2021 and June 30, 2021, respectively | 55 | 51 | ||||||
| Additional paid in capital | 291,969 | 265,130 | ||||||
| Accumulated deficit | (175,884 | ) | (147,771 | ) | ||||
| Total Akoustis Technologies, Inc. equity | $ | 116,140 | $ | 117,410 | ||||
| Noncontrolling interest | 7,528 | — | ||||||
| Total Equity | 123,668 | 117,410 | ||||||
| Total Liabilities and Equity | $ | 134,112 | $ | 124,994 | ||||
The following non-GAAP measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP. These non-GAAP measures exclude significant expenses that are required by GAAP to be recorded in the Company's financial statements and are subject to inherent limitations. Please see reconciliations to comparable GAAP measures below and descriptions of these non-GAAP measures under “Non-GAAP Measures.”
Non-GAAP Operating Loss and Non-GAAP Net Loss for the three months ending December 31, 2021, and 2020 were as follows:
| Akoustis Technologies, Inc. | ||
| Unaudited Reconciliations of Non-GAAP Financial Measures | ||
| Three Months Ended | ||
| December 31, 2021 | December 31, 2020 | |
| (in thousands) | ||
| GAAP operating loss | $ (15,215) | $ (10,221) |
| Common stock issued for services | 2,900 | 2,066 |
| Non-GAAP operating loss | $ (12,315) | $ (8,155) |
| Three Months Ended | ||
| December 31, 2021 | December 31, 2020 | |
| (in thousands) | ||
| GAAP net loss | $ (15,245) | $ (11,910) |
| Debt discount amortization | - | 1,314 |
| Gain on extinguishment of debt | - | (14) |
| Gain on sale of Fixed Assets | 2 | - |
| Common stock issued for services | 2,900 | 2,066 |
| Non-GAAP net loss | $ (12,343) | $ (8,544) |
| Weighted average common shares outstanding - basic and diluted | 52,924,078 | 39,445,268 |
| Non-GAAP net loss per common share - basic and diluted | $ (0.23) | $ (0.22) |
| Six Months Ended | ||
| December 31, 2021 | December 31, 2020 | |
| (in thousands) | ||
| GAAP operating loss | $ (28,099) | $ (20,541) |
| Common stock issued for services | 5,248 | 4,093 |
| Non-GAAP operating loss | $ (22,851) | $ (16,448) |
| Six Months Ended | ||
| December 31, 2021 | December 31, 2020 | |
| (in thousands) | ||
| GAAP net loss | $ (28,095) | $ (23,860) |
| Change in fair value of derivative liabilities | - | 184 |
| Gain on sale of Fixed Assets | (195) | - |
| Debt discount amortization | - | 2,346 |
| Common stock issued for services | 5,248 | 4,093 |
| Non-GAAP net loss | $ (23,042) | $ (17,237) |
| Weighted average common shares outstanding - basic and diluted | 52,180,077 | 38,810,985 |
| Non-GAAP net loss per common share - basic and diluted | $ (0.44) | $ (0.44) |
Non-GAAP Measures
We regularly review a number of metrics, including Non-GAAP Operating Loss and Non-GAAP Net Loss, which are not financial measures calculated in accordance with generally accepted accounting principles in the United States (“GAAP”). Non-GAAP Operating Loss represents operating loss before common stock issued for services and gain or loss on the sale of fixed assets. Non-GAAP Net Loss represents net loss before change in fair value of contingent real estate liability, change in fair value of derivative liabilities, debt discount amortization, gain on extinguishment of debt, gain or loss on sale of fixed assets and common stock issued for services. The Company believes these non-GAAP measures provide useful information to management, investors and financial analysts regarding certain financial and business trends relating to the Company’s financial condition and results of operations. We use these non-GAAP measures to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions.
About Akoustis Technologies, Inc.
Akoustis® (http://www.akoustis.com/) is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters - targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The Company utilizes its proprietary and patented XBAWTM manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of poly-crystal, high-purity and single-crystal piezoelectric materials and the resonator-filter process technology which enables optimal trade-offs between critical power, frequency and bandwidth performance specifications.
Akoustis plans to service the fast growing multi-billion-dollar RF filter market using its integrated device manufacturer (IDM) business model. The Company owns and operates a 120,000 sq. ft. ISO-9001:2015 registered commercial wafer-manufacturing facility located in Canandaigua, NY, which includes a class 100 / class 1000 cleanroom facility - tooled for 150-mm diameter wafers - for the design, development, fabrication and packaging of RF filters, MEMS and other semiconductor devices. Akoustis Technologies, Inc. is headquartered in the Piedmont technology corridor near Charlotte, North Carolina.
Forward-Looking Statements
This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, each as amended, that are intended to be covered by the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements about our estimates, expectations, beliefs, intentions, plans or strategies for the future (including our possible future results of operations, business strategies, competitive position, potential growth opportunities, potential market opportunities and the effects of competition), the anticipated benefits of the acquisition of RFMi and supply agreement with Tai-Saw, including estimated synergies and other financial impacts, and the assumptions underlying such statements. Forward-looking statements include all statements that are not historical facts and typically are identified by use of terms such as "may," “might,” “would,” "will," "should," "could," “project,” "expect," "plan," “strategy,” "anticipate," “attempt,” “develop,” “help,” "believe," “think,” "estimate," "predict," “intend,” “forecast,” “seek,” "potential," “possible,” "continue," “future,” and similar words (including the negative of any of the foregoing), although some forward-looking statements are expressed differently. Forward-looking statements are neither historical facts nor assurances of future results, performance, events or circumstances. Instead, these forward-looking statements are based on management’s current beliefs, expectations and assumptions and are subject to risks and uncertainties. Factors that could cause actual results to differ materially from those currently anticipated include, without limitation, risks relating to our ability to obtain adequate financing and sustain our status as a going concern; our limited operating history; our inability to generate revenues or achieve profitability; the results of our research and development activities; our inability to achieve acceptance of our products in the market; the possibility that the anticipated benefits from business acquisitions (including the acquisition of RFMi) cannot be realized in full or at all or may take longer to realize than expected; the possibility that costs or difficulties related to the integration of acquired businesses’ (including RFMi’s) operations will be greater than expected and the possibility of disruptions to our business during integration efforts and strain on management time and resources; the impact of a pandemic or epidemic or a natural disaster, including the COVID-19 pandemic, on our operations, financial condition and the worldwide economy, including its impact on our ability to access the capital markets; general economic conditions, including upturns and downturns in the industry; shortages in supplies needed to manufacture our products, or needed by our customers to manufacture devices incorporating our products; our limited number of patents; failure to obtain, maintain, and enforce our intellectual property rights; claims of infringement, misappropriation or misuse of third party intellectual property that, regardless of merit, could result in significant expense and loss of our intellectual property rights; our inability to attract and retain qualified personnel; our reliance on third parties to complete certain processes in connection with the manufacture of our products; product quality and defects; existing or increased competition; our ability to successfully manufacture, market and sell products based on our technologies; our ability to meet the required specifications of customers and achieve qualification of our products for commercial manufacturing in a timely manner; our ability to successfully scale our New York wafer fabrication facility and related operations while maintaining quality control and assurance and avoiding delays in output; the rate and degree of market acceptance of any of our products; our ability to achieve design wins from current and future customers; contracting with customers and other parties with greater bargaining power and agreeing to terms and conditions that may adversely affect our business; risks related to doing business in foreign countries, including China; any security breaches, cyber-attacks or other disruptions compromising our proprietary information and exposing us to liability; our failure to innovate or adapt to new or emerging technologies; our failure to comply with regulatory requirements; results of any arbitration or litigation that may arise; stock volatility and illiquidity; dilution caused by any future issuance of common stock or securities that are convertible into or exercisable for common stock; our failure to implement our business plans or strategies; and our ability to maintain effective internal control over financial reporting. These and other risks and uncertainties are described in more detail in the Risk Factors and Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of the Company’s most recent Annual Report on Form 10-K and in subsequently filed Quarterly Reports on Form 10-Q. Considering these risks, uncertainties and assumptions, the forward-looking statements regarding future events and circumstances discussed in this document may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements included in this document speak only as of the date hereof and, except as required by law, we undertake no obligation to update publicly or privately any forward-looking statements, whether written or oral, for any reason after the date of this document to conform these statements to new information, actual results or to changes in our expectations.
COMPANY: Tom Sepenzis Akoustis Technologies VP of Corporate Development & IR (980) 689-4961 tsepenzis@akoustis.com The Del Mar Consulting Group, Inc. Robert B. Prag, President (858) 794-9500 bprag@delmarconsulting.com
Released January 31, 2022